Related Experiment Video

Updated: Feb 26, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K

Cell Cycle Arrest and Apoptosis Induced by Kinamycin F in Human Osteosarcoma Cells

Alberto Bavelloni1, Enrico Focaccia1,2, Manuela Piazzi1,2

  • 1Laboratory of Musculoskeletal Cell Biology, Rizzoli Orthopedic Institute, Bologna, Italy.

Anticancer Research
|July 26, 2017
PubMed
Abstract

Insights

Kinamycin F, a bacterial compound, effectively triggers cell death in osteosarcoma cell lines by inducing apoptosis and halting cell cycle progression. This suggests its potential as a novel therapeutic agent for osteosarcoma treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Kinamycin F is a bacterial metabolite with a unique diazo group known to inhibit cell growth.
  • Its potential as an anti-tumor agent against osteosarcoma warrants investigation due to a potentially novel target.

Purpose of the Study:

  • To investigate the anti-tumor activity of Kinamycin F in human osteosarcoma cell lines.
  • To elucidate the mechanism of Kinamycin F-induced cell death.

Main Methods:

  • Cell viability and proliferation assays were performed on MG-63, U-2 OS, and HOS cell lines.
  • Cell cycle progression was analyzed using Muse™ Cell Analyzer.
  • Caspase-3 activity and protein levels of cyclin D3, cyclin A, and CDK-2 were assessed.

Main Results:

  • Kinamycin F induced concentration-dependent cell death in all tested osteosarcoma cell lines.
  • Treatment with Kinamycin F led to a significant increase in the G2/M phase cell population.
  • Kinamycin F activated caspase-3, indicating apoptosis induction, and suppressed proliferation by affecting cyclin A and D3 expression.

Conclusions:

  • Kinamycin F effectively induces apoptosis and inhibits proliferation in osteosarcoma cells.
  • The mechanism involves cell cycle arrest at the G2/M phase and modulation of key cell cycle regulatory proteins.
  • Kinamycin F shows promise as a novel therapeutic agent for osteosarcoma (OS).
Keywords:
Osteosarcomascell deathcyclin D3kinamycin F

More Related Videos

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

8.9K
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.3K

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
4.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K